Crossmark

Pemetrexed and platinum with or without pembrolizumab for advanced non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis

Published Online: 2024-10-15

Authors

Zhao, Zichen

Yang, Chuchu

Li, Jiashu https://orcid.org/0009-0000-0723-3606
License Information

Text and Data Mining valid from 2024-10-15

Version of Record valid from 2024-10-15
More Information

Article History

Received: 12 June 2024

Accepted: 1 October 2024

First Online: 15 October 2024

Declarations

:

: Not applicable.

: The authors declare that there are no conflicts of interest.

Document is current